AETHLON MEDICAL INC 4
4 · AETHLON MEDICAL INC · Filed Feb 8, 2017
Insider Transaction Report
Form 4
Joyce James A
DirectorChair., Pres., CEO, CFO, Sec.10% Owner
Transactions
- Disposition to Issuer
Restricted Stock Units
2017-02-07−98,107→ 535,893 total→ Common Stock (98,107 underlying) - Exercise/Conversion
Common Stock
2017-02-07$4.28/sh+98,107$419,898→ 98,107 total
Footnotes (3)
- [F1]In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016.
- [F3]158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17Represents conversion of restricted stock units with common stock issued on February 7, 2017.